Hepatocellular Carcinoma: Advances in Multidisciplinary Management
PROGRAM DESCRIPTION Expert faculty Richard Finn, MD, discusses treatment options and strategies in a case-based approach for two patients who have failed conventional therapies and may be candidates for immunotherapy. ...
PROGRAM DESCRIPTION
Expert faculty Richard Finn, MD, discusses treatment options and strategies in a case-based approach for two patients who have failed conventional therapies and may be candidates for immunotherapy. The activity features an online virtual patient platform that affords clinicians an opportunity to absorb relevant clinical and evidence-based information.
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be able to:Differentiate the mechanisms of action and scientific rationale of currently available systemic therapies with the use of immunotherapy approaches in advanced HCCDiscuss the role of new and emerging immunotherapies in current treatment paradigms for advanced HCCReview the efficacy, safety and tolerability of emerging agents for advanced HCC and the management of immune-related adverse eventsEvaluate the evolving immunotherapeutic research landscape, including ongoing studies in earlier stages of disease as well as personalized and locoregional therapies
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags
